StockData
Definium Therapeutics, Inc. logo

Definium Therapeutics, Inc. (DFTX) stock

DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$29.38−0.78 (-2.59%)

Close on Nov 17, 2026Market cap $3.95BP/E –Yield –

Definium Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Definium Therapeutics's total debt was $36.47M at Jun 30, 2026. For fiscal 2025 it was $40.58M, up 85.7% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$40.58M+85.7%
FY2024Dec 31, 2024$21.85M+54.7%
FY2023Dec 31, 2023$14.13M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$36.47M-11.5%
Q1 FY2026Mar 31, 2026$40.77M+85.0%
Q4 FY2025Dec 31, 2025$40.58M+85.7%
Q3 FY2025Sep 30, 2025$40.39M+66.1%
Q2 FY2025Jun 30, 2025$41.19M+69.9%
Q1 FY2025Mar 31, 2025$22.04M+55.3%
Q4 FY2024Dec 31, 2024$21.85M+54.7%
Q3 FY2024Sep 30, 2024$24.31M+72.8%
Q2 FY2024Jun 30, 2024$24.25M–
Q1 FY2024Mar 31, 2024$14.19M–
Q4 FY2023Dec 31, 2023$14.13M–
Q3 FY2023Sep 30, 2023$14.07M–

More Definium Therapeutics figures

See a number that looks wrong?